• Canadian Uranium restated its unaudited interim financial statements for the three months ended March 31, 2026, following a BC Securities Commission review.
• Restatement revised the fair value of 8,255,187 shares issued for the Impact Uranium acquisition to use the March 17, 2026 closing price.
• MD&A disclosures were corrected to consistently state the acquisition closed on March 17, 2026.
• No change to the statement of loss and comprehensive loss or cash flow statement for the quarter.
• Previously filed interim financial statements and MD&A from May 28, 2026 should no longer be relied upon.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canadian Uranium Corp. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202608202010TNWSWRCACNPR_____1A0vFm4xz) on August 21, 2026, and is solely responsible for the information contained therein.